Europe (English)
▾
Global
English
United States
English
Europe
English
✓
Italiano
Latin America
Português
Español
Contact Us
Product
Publication
Knowledge
Education
Training
Video Resources
News
News & Insight
Events
About
Contact Us
Europe (English)
▾
Global
English
United States
English
Europe
English
✓
Italiano
Latin America
Português
Español
Product
Publication
Knowledge
Education
Training
Video Resources
News
News & Insight
Events
About
Contact Us
Day
May 27, 2025
Training
,
Wound Care
•
2025-05-27
•
Nelly Wang
Treatment of Diabetic Foot Ulcers
The treatment process for diabetic foot is extremely complex and requires collaboration across multidisciplinary team members.
Read More
Education
,
Wound Care
•
2025-05-27
•
Nelly Wang
Global Status and Challenges of Diabetic Foot Ulcers (DFU): A Growing Public Health Concern
Diabetic Foot Ulcers (DFU) represent a significant and escalating complication of diabetes, affecting millions worldwide.
Read More
Recent articles
ON101 Named Among the Global Top 15 in the ADA 2026 Innovation Challenge
2026-05-29
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by Health Canada.
2026-05-11
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by ThaiFDA.
2026-05-11
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by AMMPS Morocco.
2026-04-10
EU NB issued the EU market approval for Bonvadis® that grants marketing authorization across all 27 EU member states for acute and chronic wounds, and scar management.
2026-03-12
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia.
2026-02-22
The medical device registration application of Bonvadis® for all indications of wounds has been accepted by INVIMA Colombia.
2026-01-31
